Kate Quirke @ 121 investment conference Hong Kong 13-14 June 2018
https://www.weare121.com/121techinvestment-hk/alcidion/
Kate Quirke, CEO
Kate is a highly experienced executive with a deep expertise in the healthcare IT sector. Kate was previously the CEO of MKM Health for the past two years, and prior to this role she was the Head of Sales and Marketing at MKM Health. Since initially joining MKM Health as Sales Director in FY2012, Kate has increased MKM Health revenues by over 2.5 times, achieving a compound average annual growth rate of 29%.
What is your rationale for attending 121 Tech Investment?
Alcidion is looking for strategic and financial investors who share in its vision and long-term growth strategy; seek new international market opportunities across Singapore, Hong Kong and Malaysia
What recent news would you like to highlight to investors attending?
Transformative acquisition of health informatics software and services company MKM health in Australia and New Zealand, and Patientrack in the UK.
The transformative Acquisition creates a new and leading specialist health IT solution provider focused on “next generation” decision intelligence technology designed for hospital and allied healthcare customers globally. Patientrack and Alcidion’s existing Miya and Smartpage product sets will provide the expanded group with a strong foundation of complementary technologies.
What are your key goals for the next 3, 6 and 12 months?3 MONTH GOALSIntegrate key MKM Health sales & marketing personnel
Leverage domestic MKM Health relationships
6 MONTH GOALSLaunch integrated Patientrack and Miya PatientFlow product offering
New analytics & advanced metrics products to be launched in 2018
Further investment in UK sales and marketing team
12 MONTH GOALSExploring additional point-of-care product offering
Cross-selling of Miya products into UK market
What do you see as the key risks and challenges facing your company at the moment and how are you overcoming these?
In a sentence, what do you think makes your company such a compelling investment?
Alicidion offers leading healthcare system integration, implementation and software support capabilities, required by both individual healthcare providers and state health agencies to build integrated health informatics platforms, a necessary basis in order to deliver truly integrated healthcare.
- Forums
- ASX - By Stock
- ALC
- General Discussion / Social Media
General Discussion / Social Media, page-28
- There are more pages in this discussion • 6,076 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALC (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.5¢ |
Change
0.001(1.85%) |
Mkt cap ! $73.83M |
Open | High | Low | Value | Volume |
5.5¢ | 5.9¢ | 5.3¢ | $168.1K | 2.998M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 78405 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.053 |
3 | 381968 | 0.050 |
1 | 61200 | 0.049 |
3 | 173800 | 0.047 |
2 | 58818 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 78405 | 3 |
0.056 | 143438 | 2 |
0.057 | 5000 | 1 |
0.059 | 66384 | 2 |
0.060 | 265462 | 5 |
Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
Last
5.3¢ |
  |
Change
0.001 ( 1.15 %) |
|||
Open | High | Low | Volume | ||
5.6¢ | 5.9¢ | 5.3¢ | 1081166 | ||
Last updated 15.59pm 26/04/2024 ? |
Featured News
ALC (ASX) Chart |